Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Kimberly Maurel

Showing results (1-10 of 17) with videos related to

Pageof 2
Sort By:
American Journal of Obstetrics and Gynecology|March 4, 2009
Impact of a 'rescue course' of antenatal corticosteroids: a multicenter randomized placebo-controlled trialThomas J Garite, James Kurtzman, Kimberly Maurel, et al.
American Journal of Perinatology|February 26, 2014
Fetal fibronectin versus cervical length as predictors of preterm birth in twin pregnancy with or without 17-hydroxyprogesterone caproateC Andrew Combs, Thomas J Garite, Kimberly Maurel, et al.
American Journal of Obstetrics and Gynecology|September 7, 2010
Failure of 17-hydroxyprogesterone to reduce neonatal morbidity or prolong triplet pregnancy: a double-blind, randomized clinical trialC Andrew Combs, Thomas Garite, Kimberly Maurel, et al.
AJOG Global Reports|September 28, 2022
Disseminated intravascular coagulation complicating mild or asymptomatic maternal COVID-19Jeanette Carpenter, C Andrew Combs, Bronwen Kahn, et al.
American Journal of Obstetrics and Gynecology|March 8, 2011
17-hydroxyprogesterone caproate for twin pregnancy: a double-blind, randomized clinical trialC Andrew Combs, Thomas Garite, Kimberly Maurel, et al.
The Journal of Maternal-Fetal & Neonatal Medicine : the Official Journal of the European Association of Perinatal Medicine, the Federation of Asia and Oceania Perinatal Societies, the International Society of Perinatal Obstetricians|June 12, 2018
Estimating risk of severe neonatal morbidity in preterm births under 32 weeks of gestationEmily F Hamilton, Alina Dyachenko, Antonio Ciampi, et al.
BMC Research Notes|December 31, 2011
17-Hydroxyprogesterone caproate to prolong pregnancy after preterm rupture of the membranes: early termination of a double-blind, randomized clinical trialC Andrew Combs, Thomas J Garite, Kimberly Maurel, et al.
American Journal of Obstetrics and Gynecology|March 25, 2014
Noninvasive prenatal screening for fetal trisomies 21, 18, 13 and the common sex chromosome aneuploidies from maternal blood using massively parallel genomic sequencing of DNARichard P Porreco, Thomas J Garite, Kimberly Maurel, et al.
American Journal of Obstetrics and Gynecology|March 8, 2017
A multicenter prospective study of neonatal outcomes at less than 32 weeks associated with indications for maternal admission and deliveryThomas J Garite, C Andrew Combs, Kimberly Maurel, et al.
American Journal of Obstetrics and Gynecology|March 6, 2016
Vasa previa: diagnosis and managementMorgan L Swank, Thomas J Garite, Kimberly Maurel, et al.
Pageof 2

Showing results (1-10 of 17) with videos related to

Sort By:
Pageof 2
American Journal of Obstetrics and Gynecology|March 4, 2009
Impact of a 'rescue course' of antenatal corticosteroids: a multicenter randomized placebo-controlled trialThomas J Garite, James Kurtzman, Kimberly Maurel, et al.
American Journal of Perinatology|February 26, 2014
Fetal fibronectin versus cervical length as predictors of preterm birth in twin pregnancy with or without 17-hydroxyprogesterone caproateC Andrew Combs, Thomas J Garite, Kimberly Maurel, et al.
American Journal of Obstetrics and Gynecology|September 7, 2010
Failure of 17-hydroxyprogesterone to reduce neonatal morbidity or prolong triplet pregnancy: a double-blind, randomized clinical trialC Andrew Combs, Thomas Garite, Kimberly Maurel, et al.
AJOG Global Reports|September 28, 2022
Disseminated intravascular coagulation complicating mild or asymptomatic maternal COVID-19Jeanette Carpenter, C Andrew Combs, Bronwen Kahn, et al.
American Journal of Obstetrics and Gynecology|March 8, 2011
17-hydroxyprogesterone caproate for twin pregnancy: a double-blind, randomized clinical trialC Andrew Combs, Thomas Garite, Kimberly Maurel, et al.
The Journal of Maternal-Fetal & Neonatal Medicine : the Official Journal of the European Association of Perinatal Medicine, the Federation of Asia and Oceania Perinatal Societies, the International Society of Perinatal Obstetricians|June 12, 2018
Estimating risk of severe neonatal morbidity in preterm births under 32 weeks of gestationEmily F Hamilton, Alina Dyachenko, Antonio Ciampi, et al.
BMC Research Notes|December 31, 2011
17-Hydroxyprogesterone caproate to prolong pregnancy after preterm rupture of the membranes: early termination of a double-blind, randomized clinical trialC Andrew Combs, Thomas J Garite, Kimberly Maurel, et al.
American Journal of Obstetrics and Gynecology|March 25, 2014
Noninvasive prenatal screening for fetal trisomies 21, 18, 13 and the common sex chromosome aneuploidies from maternal blood using massively parallel genomic sequencing of DNARichard P Porreco, Thomas J Garite, Kimberly Maurel, et al.
American Journal of Obstetrics and Gynecology|March 8, 2017
A multicenter prospective study of neonatal outcomes at less than 32 weeks associated with indications for maternal admission and deliveryThomas J Garite, C Andrew Combs, Kimberly Maurel, et al.
American Journal of Obstetrics and Gynecology|March 6, 2016
Vasa previa: diagnosis and managementMorgan L Swank, Thomas J Garite, Kimberly Maurel, et al.
Pageof 2